A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps
1527-0001
Phase 1 other active
Quick answer
A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps for Melanoma, Solid tumours is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Melanoma, Solid tumours
- Phase
- Phase 1
- Modality
- other
- Status
- active